P. Schoenfeld Asset Management (PSAM)’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
P. Schoenfeld Asset Management (PSAM)'s ALDR Position: Q4 2019 in Review
P. Schoenfeld Asset Management (PSAM) sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 2,372,000 shares — an estimated $44.7M sold.
P. Schoenfeld Asset Management (PSAM) first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $44.7M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- P. Schoenfeld Asset Management (PSAM) reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- P. Schoenfeld Asset Management (PSAM) sold 2,372,000 Alder Biopharmaceuticals shares in Q4 2019, an estimated $44.7M.
- P. Schoenfeld Asset Management (PSAM) first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
- P. Schoenfeld Asset Management (PSAM)'s Alder Biopharmaceuticals position peaked at $44.7M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q4 2019, filed 14 Feb 2020.